Pharmafile Logo
Pharmafocus logo
Advanced Search
BI Centre_03 2

Boehringer’s ovarian cancer drug enters phase III

December 18, 2009
Research and Development, Sales and Marketing Boehringer, Cancer, ovarian

Boehringer Ingelheim has started a new phase III trial for its investigational cancer drug BIBF 1120. The LUME-Ovar-1 programme will …

News

UK supports stem cell research with online toolkit

December 18, 2009
Research and Development ReNeuron, regenerative medicine, stell cell

A new online resource has been launched to help stem cell researchers in the UK plan a regulatory route for …

News
Sir-Liam-Donaldson

Sir Liam Donaldson steps down as England’s chief medical officer

December 18, 2009
Liam Donaldson, NHS, UK, appointment

England’s chief medical officer Sir Liam Donaldson will step down in May 2010 after 12 years of service. Details for …

Appointment
InternetHands

ScopeMedical boosts digital offering

December 18, 2009
Medical Communications ScopeMedical, digi

Kent-based med ed agency ScopeMedical has boosted its in-house digital offering and says there are plans to grow it further …

News
Chris Begley

Hospira buys Orchid generic injectables business for $400m

December 18, 2009
Manufacturing and Production Hospira, India, Orchid, injectables

Indian active pharmaceutical ingredient manufacturer Orchid Chemicals & Pharmaceuticals has signed a $400 million deal to sell the assets of …

News
NICElr

NICE still saying ‘no’ to Roche’s RoActemra

December 17, 2009
Sales and Marketing NICE, RoActemra, Roche

Roche will have to present a stronger case for arthritis drug RoActemra in order to gain approval, according to NICE. …

News
ICON headquarters

ICON investments will come to fruition in 2010

December 16, 2009
Research and Development ICON, Manchester, translational

Irish contract research organisation ICON has provided additional details on its new translational medicine unit in Manchester, UK, first announced …

News
Blog footer

Digital Pharma: A Year in Digital (5/5)

December 16, 2009
Medical Communications 2009, Boehringer, digi, digital pharma, year in review

Favourite use of digital (pharma)• Microsoft’s future of healthcare video. It’s their vision of the possibilities that I fell in …

Feature

GSK signs needle-free vaccine alliance

December 16, 2009
Research and Development, Sales and Marketing GlaxoSmithKline, Intercell, patch, vaccines

GlaxoSmithKline has signed a deal with Intercell to see whether any of its vaccines could be made available in patch …

News

Sanofi invests in syringe production in France

December 16, 2009
Manufacturing and Production France, Sanofi-Aventis, vaccines

Sanofi-Aventis has doubled its capacity to manufacture syringe-delivered medicines with the opening of new production units at Le Trait, near …

News
ScopeMedical-Toby,-Carol,-Chris

Three new starters at ScopeMedical

December 16, 2009
Medical Communications ScopeMedical, appointment, medical communications

ScopeMedical has appointed Toby Galbraith as account director, Carol Richter as medical writer and Chris Tilly as account manager.Toby has …

Appointment

GSK discloses US healthcare professional payments

December 15, 2009
Medical Communications GSK, doctors, industry reputation, payments

GlaxoSmithKline has disclosed some of the fees it has paid to US healthcare professionals for speaking and consulting services.The list …

News
Bayer Schering Pharma's Len Starnes

Digital Pharma: A Year in Digital (4/5)

December 15, 2009
Medical Communications 2009, Bayer, digi, digital pharma, year in review

Favourite use of digital (pharma)Physicians’ social networks. This is pharma’s new engagement channel offering the industry an opportunity to normalise …

Feature
EU flag

Commission launches new wave of anti-trust raids

December 15, 2009
Sales and Marketing Europe, European Commission, Lundbeck, Teva, generics, kroes

The European Commission has launched a new series of raids on pharmaceutical companies as part of its crackdown on alleged …

News
Nestle HQ image

The future is personalised

December 15, 2009
Research and Development, Sales and Marketing diagnostic, industry, nestle, personalised, pricewaterhousecoopers

A new report says the market for personalised medicine products is set to grow strongly over the next few years, …

News

Patheon will shed another Puerto Rico plant

December 15, 2009
Manufacturing and Production JLL, Patheon, Puerto Rico

Contract manufacturer Patheon has taken the axe to its Puerto Rico operations once again, this time marking its facility in …

News

Kendle appoints Christopher Bergen chief administrative officer and Simon Higginbotham chief marketing officer

December 15, 2009
Research and Development Kendle, appointment, research and development

Kendle has appointed Christopher Bergen to the newly-created role of chief administrative officer and executive vice president.Bergen was previously chief …

Appointment
Chris-Brinsmead100

AstraZeneca’s Chris Brinsmead and ex-health minister Lord Darzi appointed ambassadors for UK lifescience

December 15, 2009
Research and Development, Sales and Marketing AstraZeneca, Darzi, UK, appointment, research and development, sales and marketing

AstraZeneca UK’s chairman Chris Brinsmead and former health minister Lord Ara Darzi are among six newly appointed private sector business …

Appointment

Vision for £500m biomedical research hub in UK unveiled

December 14, 2009
Research and Development Paul Nurse, UKCMRI, Wellcome

Construction of a new biomedical research institute designed to bring the UK to the forefront of fundamental research in a …

News

Pharma welcomes UK pre-budget report

December 14, 2009
Research and Development patent, tax

The pharma and healthcare sectors have been unpicking the implications of last week’s Pre-Budget Report (PBR) by chancellor Alastair Darling.The …

News
The Gateway to Local Adoption Series

Latest content

MRM Health’s ulcerative colitis treatment receives FDA Investigational New Drug clearance

January 27, 2026

Crystalys Therapeutics appoints Justin Thacker as Chief Financial Officer

January 27, 2026

Rentschler Biopharma appoints Uwe Buecheler as interim CEO

January 26, 2026

Sandoz’ Ondibta receives European Commission approval for diabetes

January 26, 2026

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026